Elmariah et al. suggested that a panel of multiple biomarkers including age, NT-proBNP, vWF, and fetuin-A would be valuable for the identification of high-risk patients with aortic stenosis and for timely valve intervention (Elmariah et al., 2018). The gene discussed is NPPB; the disease is aortic stenosis.